Back to
Invesco Ltd.
SMMT
Showing 8 of 19 quarters
Position history for
Invesco Ltd.'s holdings in Summit Therapeutics Inc.
Yes. Invesco holds 416,847 shares of SMMT (Summit Therapeutics), worth $6.1M, as of its Q2 2026 13F filing. It reduced the position by 109,256 shares (-20.8%) from Q1 2026. Invesco has held SMMT since Q1 2023, across 14 quarterly 13F filings.
Current Value
$6.1M
Current Shares
416,847
Total Value Change
+$4.4M
Total Shares Change
+342,352
Quarter-by-Quarter History